Quince Therapeutics, Inc.
USD18.78
-0.04 (-0.21%)
CEO
Dirk Thye
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.55
Prev. Close
$18.82
Day Low
$18.52
Day High
$19.14
52W Low
$15.10
52W High
$910.00
Market Cap
$0.01B
Volume
0.01M
| 2,700 |
| $0.95 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 34,675 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 228,855 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 124,830 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 69,350 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 362,092 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 133,615 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 2,070,107 | $0.09 |
| 11 Jun 2026 | Roberts Brigette | director, officer: Chief Corp. Affairs Officer | A-Award | Acquired | 6,837,319 | $0.84 |